Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9Genitourinary 3Gastrointestinal 3Myeloid 2Lymphoid 2CNS 2Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 92Fallopian Tube Neoplasms 25Breast Neoplasms 21Endometrial Neoplasms 19Carcinoma, Ovarian Epithelial 12Triple Negative Breast Neoplasms 7Prostatic Neoplasms 7Pancreatic Neoplasms 7Neoplasms 6Fanconi Anemia, Complementation Group D1 5Uterine Cervical Neoplasms 4Recurrence 4Neoplasm Metastasis 4Carcinoma, Renal Cell 3Uterine Neoplasms 2Stomach Neoplasms 2Peritoneal Neoplasms 2Ovarian Diseases 2Carcinosarcoma 2Carcinoma, Non-Small-Cell Lung 2Urogenital Neoplasms 1Triple Negative Metastatic Breast Cancer 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Relapsed Ovarian Cancers Patients 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Prostatic Neoplasms, Castration-Resistant 1Platinum-sensitive Ovarian Cancer 1Platinum-Refractory Fallopian Tube Carcinoma 1

Interventions

Filgrastim 15Carboplatin 10Ifosfamide 9Doxorubicin 9Cyclophosphamide 9Peripheral Blood Stem Cell Transplantation 7pembrolizumab 6Radiotherapy 6Gemcitabine 6Temozolomide 5Etoposide 5Cisplatin 5Paclitaxel 4Docetaxel 4Amifostine 4aldesleukin 3aflibercept 3Trastuzumab 3Specimen Handling 3Radiosurgery 3Psychiatric Rehabilitation 3Magnetic Resonance Spectroscopy 3Biopsy 3tislelizumab 2sodium thiosulfate 2selinexor 2pazopanib 2palbociclib 2etoposide phosphate 2eribulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × olaparib × Gynecologic × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡